The 2013 American Urological Association (AUA) Urologic Oncology Program “Overcoming Hurdles in Urologic Cancer Research," will be held on Friday, May 3, during the 2013 AUA Annual Meeting in San Diego, California.
The 2013 AUA Urologic Oncology program will provide a forum for broad-based education of both basic scientists moving into urologic research as well as clinical and translational urologic researchers with an interest in basic science. Critical ideas and concepts will be presented allowing participants to conceptualize cross collaborations between different areas of research. Traditionally research has been broken into “silos” composed of basic science and health services research. One of the goals of this conference is to allow researchers from both “silos” to interact with each other. This cross-talk is expected to spawn not only collaborative projects, but also lead to more productive and efficient translational research in which laboratory bench findings can propel health services research and vice-versa.
The conference benefits from the synergy of new investigators and successful senior researchers in a comfortable, informal setting. The information discussed and shared during this meeting is expected to assist in translating clinical research to practical application. It is also intended to serve as a forum where young investigators have the opportunity to meet and interact with leaders in the fields of epigenetics, targeted therapies, focal imaging and health services related to urologic oncology. By learning more about on these topics and the future of team science and personalized medicine from the most respected scientists in the world, junior investigators will be in better positions to understand the pathogenesis of these disorders and to formulate novel translational approaches. The connections made during the meeting are expected to stimulate research collaborations and promote this exciting area of research to the next generation of investigators.
The meeting will be divided into a morning session, “Cancer and Epigenetic Pathways to Therapy,” and an afternoon session, “Tumor Biology – New Breakthroughs In Cancer Detection and Therapy,” The agenda includes presentations from nationally renowned scientists, point-counter point discussions and panel discussions.
Leaders of the AUA and its affiliated specialty societies, including the Society of Urologic Oncology (SUO) and the Society for Basic Urologic Research (SBUR) will be invited to attend. Scientific and program officers from the National Cancer Institute will also be invited to attend.